List of Oxford Biomedica (UK) Limited patents

Patents where

Current Assignee

Name

‌

Oxford Biomedica (UK) Limited

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7303910 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site	Patent 7303910 was granted and assigned to Oxford Biomedica (UK) Limited on December, 2007 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7303910	December 4, 2007
‌ US Patent 7575916 Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 tumor-associated antigen and vector comprising the nucleic acid molecule	Patent 7575916 was granted and assigned to Oxford Biomedica (UK) Limited on August, 2009 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7575916	August 18, 2009
‌ US Patent 7070994 Packaging cells	Patent 7070994 was granted and assigned to Oxford Biomedica (UK) Limited on July, 2006 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7070994	July 4, 2006
‌ US Patent 6969598 Methods for producing high titre vectors and compositions used in such methods	Patent 6969598 was granted and assigned to Oxford Biomedica (UK) Limited on November, 2005 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	6969598	November 29, 2005
‌ US Patent 7198784 Retroviral vectors	Patent 7198784 was granted and assigned to Oxford Biomedica (UK) Limited on April, 2007 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7198784	April 3, 2007
‌ US Patent 11427645 5T4-targeting agents and methods	Patent 11427645 was granted and assigned to Oxford Biomedica (UK) Limited on August, 2022 by the United States Patent and Trademark Office.	‌ Oxford Biomedica (UK) Limited	‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	11427645	August 30, 2022
‌ US Patent 6924123 Lentiviral LTR-deleted vector	Patent 6924123 was granted and assigned to Oxford Biomedica (UK) Limited on August, 2005 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	6924123	August 2, 2005
‌ US Patent 7419829 Vector system	Patent 7419829 was granted and assigned to Oxford Biomedica (UK) Limited on September, 2008 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7419829	September 2, 2008
‌ US Patent 7615612 Polypeptide	Patent 7615612 was granted and assigned to Oxford Biomedica (UK) Limited on November, 2009 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7615612	November 10, 2009
‌ US Patent 9339512 Method for vector delivery	Patent 9339512 was granted and assigned to Oxford Biomedica (UK) Limited on May, 2016 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	9339512	May 17, 2016
‌ US Patent 8084249 Vector	Patent 8084249 was granted and assigned to Oxford Biomedica (UK) Limited on December, 2011 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	8084249	December 27, 2011
‌ US Patent 7635687 Vector system	Patent 7635687 was granted and assigned to Oxford Biomedica (UK) Limited on December, 2009 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7635687	December 22, 2009
‌ US Patent 7531648 Vector encoding an antibody that binds 5T4 antigen	Patent 7531648 was granted and assigned to Oxford Biomedica (UK) Limited on May, 2009 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7531648	May 12, 2009
‌ US Patent 7585676 Retroviral vector	Patent 7585676 was granted and assigned to Oxford Biomedica (UK) Limited on September, 2009 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7585676	September 8, 2009
‌ US Patent 7541044 Administration of 5T4 antigen and immune response of cells expressing 5T4 and CEA antigens	Patent 7541044 was granted and assigned to Oxford Biomedica (UK) Limited on June, 2009 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7541044	June 2, 2009
‌ US Patent 7718627 Vector	Patent 7718627 was granted and assigned to Oxford Biomedica (UK) Limited on May, 2010 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7718627	May 18, 2010
‌ US Patent 8133681 Chemo-immunotherapy method	Patent 8133681 was granted and assigned to Oxford Biomedica (UK) Limited on March, 2012 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	8133681	March 13, 2012
‌ US Patent 7888115 MHC class I peptide epitopes from the human 5T4 tumor-associated antigen	Patent 7888115 was granted and assigned to Oxford Biomedica (UK) Limited on February, 2011 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7888115	February 15, 2011
‌ US Patent 7659383 Feline 5T4 antigen	Patent 7659383 was granted and assigned to Oxford Biomedica (UK) Limited on February, 2010 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7659383	February 9, 2010
‌ US Patent 7666669 Polypeptide	Patent 7666669 was granted and assigned to Oxford Biomedica (UK) Limited on February, 2010 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7666669	February 23, 2010
‌ US Patent 9169491 Virus purification	Patent 9169491 was granted and assigned to Oxford Biomedica (UK) Limited on October, 2015 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	9169491	October 27, 2015
‌ US Patent 8147838 Peptide	Patent 8147838 was granted and assigned to Oxford Biomedica (UK) Limited on April, 2012 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	8147838	April 3, 2012
‌ US Patent 10544429 Viral vector production system	Patent 10544429 was granted and assigned to Oxford Biomedica (UK) Limited on January, 2020 by the United States Patent and Trademark Office.	‌ Oxford Biomedica (UK) Limited	‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	10544429	January 28, 2020
‌ US Patent 7276488 Vector system	Patent 7276488 was granted and assigned to Oxford Biomedica (UK) Limited on October, 2007 by the United States Patent and Trademark Office.		‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	7276488	October 2, 2007
‌ US Patent 10273502 Virus purification	Patent 10273502 was granted and assigned to Oxford Biomedica (UK) Limited on April, 2019 by the United States Patent and Trademark Office.	‌ Oxford Biomedica (UK) Limited	‌ Oxford Biomedica (UK) Limited	United States Patent and Trademark Office	10273502	April 30, 2019

Results per page:

30 results

0 selected

30 results

0 selected